Article
Exploratory post-hoc survival evaluation in M1 prostate cancer patients treated with bicalutamide ("Casodex")
AV Kaisary,Peter Iversen,CJ Tyrrell,J. Anderson,H VanPoppel,Teuvo L.J. Tammela+1 more-1998-01-01-UCL Discovery (University College London)
0
Chat with Paper
AI Agents for this Paper
No abstract available for this paper.
Keywords
BicalutamideProstate cancerOncologyPost-hoc analysisPost hocMedicineInternal medicineCancer
Chat
Click to start Chat